Vernalis Plc (VER) Company Profile - CorporateInformation.com

Company Search:

Advanced Search

Wright Investors Service Perspectives


	The Wright Reports site is no longer hosted or operated by Manta. Please review the following: 1. You have been redirected to CorporateInformation.com where you can view Snapshot reports or purchase Wright reports or subscriptions of your choosing. 2. If you were previously linking to Wright Reports please change your links to www.corporateinformation.com 3. If you are a paid subscriber with an active subscription please continue on to the member site: http://member.corporateinformation.com/home.asp 4. For additional information related to CorporateInformation.com please contact help@corporateinformation.com, Contact phone nr to be provided later)

Vernalis Plc Company Snapshot

Business Description:

Vernalis Plc operates in the Pharmaceutical preparations sector. Vernalis plc is a United Kingdom based company. It is a development stage pharmaceutical company. As of December 31, 2010, the Company had one marketed product frovatriptan. The Company's development portfolio consists of five programmes in clinical development, three of which are partnered. The Company is engaged in the research, development and commercialization of pharmaceutical products for a range of medical disorders. Its product pipeline includes Frovatriptan, V158866, V81444, V3381, V2006, AUY922, CHR2797, HSP990, V158411, V85546, RPL554 and V10153. As of December 31, 2010, Vernalis had two development products in the CNS therapeutic area, the FAAH inhibitor V158866 for pain and a next-generation adenosine A2A antagonist as a treatment for Parkinson's disease (PD).The Company's pipeline focuses on several disease areas in central nervous system (CNS) and oncology. In our complete report available for purchase the company is compared to: Plethora Solution Holdings PLC, Sinclair Pharma PLC and Oxford BioMedica plc.

Vernalis Plc

Stock Performance Chart for Vernalis Plc

Stock Data:

Recent Stock Performance:

Current Price (2/3/2012): 19.25p
(Figures in Pounds Sterling)

1 Week	0.0%		13 Weeks	-3.1%

4 Weeks	-32.5%		52 Weeks	-59.9%

Vernalis Plc Key Data:

	Ticker:	VER	Country:	UNITED KINGDOM

	Exchanges:	LON	Major Industry:	Drugs, Cosmetics & Health Care

			Sub Industry:	Ethical Drug Manufacturers

	2010 Sales	14,197,000 (Year Ending Jan 2011).	Employees:	85

	Currency:	Pounds Sterling	Market Cap:	19,170,113

	Fiscal Yr Ends:	December	Shares Outstanding:	99,585,000

	Share Type:	Ordinary	Closely Held Shares:	65,526,046

Feedback | Terms and Conditions | Privacy Policy | Site Index

CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.